Skip to main content

Table 1 General characteristics of study participants at baseline study

From: Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients

  Placebo group
(n = 30)
Vitamin D plus probiotic group
(n = 30)
P1
Age (y) 43.2 ± 6.0 44.8 ± 8.3 0.41
Gender
 Female 2 (6.7) 2 (6.7) > 0.99†
 Male 28 (93.3) 28 (93.3)  
Height (m) 168.6 ± 7.5 170.6 ± 6.0 0.24
Weight at study baseline (kg) 69.5 ± 10.7 67.2 ± 9.0 0.38
Weight at end-of-trial (kg) 69.5 ± 10.5 67.5 ± 8.7 0.42
Body weight change (kg) 0.04 ± 0.7 0.2 ± 1.2 0.43
BMI at study baseline (kg/m2) 24.5 ± 3.7 23.1 ± 2.8 0.11
BMI at end-of-trial (kg/m2) 24.5 ± 3.7 23.2 ± 2.7 0.12
BMI change (kg/m2) 0.01 ± 0.2 0.1 ± 0.4 0.46
  1. Data are means± SDs
  2. 1Obtained from independent samples t-test
  3. Obtained from Fisher’s exact test